Intravenous immunoglobulin for mortality and inflammatory status in patients with sepsis: a retrospective database study
The administration of IVIG was associated with a reduction in sepsis mortality and favorable outcomes in laboratory parameters and the functional status. These results will contribute to the ongoing debate on the efficacy of IVIG for sepsis. The results obtained herein suggest the benefit of IVIG, particularly in mitigating PICS. Further research, including prospective studies, is warranted to confirm these results and examine long-term outcomes.
Authors
- Hiroyuki Ohbe (ORCID: https://orcid.org/0000-0001-8544-2569)
- Yuji Wakimoto (ORCID: https://orcid.org/0009-0006-1013-7440)
- Kensuke Nakamura (ORCID: https://orcid.org/0000-0002-1010-3228)
- Hayabusa Takano
- Naoki Kanda (ORCID: https://orcid.org/0000-0001-8003-534X)
Institutions
- Jichi Medical University (JP)
- Tohoku University Hospital (JP)
- Yokohama City University Hospital (JP)
- Showa General Hospital (JP)
- Hitachi General Hospital (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-16
- DOI
- https://doi.org/10.3389/fimmu.2024.1511481
- Citations
- 1
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Japan Blood Products Organization